1 Product identity

Ingredient risk

Contains restricted ingredients

Migrahills

Name: Migrahills
Brand: Herbal Hills

BrandHerbal Hills→Other Combinations Tablet or Pill 11 ingredients 1 banned DSLD #203751

Net contents: 900 Tablet(s)

Target: Adults and Children 4 years and above

DSLD entry: 2019-06-24

2 Ingredients (11)

IngredientGroupSafety

Godanti BhasmaSeleniumConditionally Safe

Sajjikshar powderPotassium carbonate—

Pippalimool powderIndian Long Pepper—

Dashamool extractBlend (Herb/Botanical)—

Ashwagandha extractAshwagandhaBanned in ≥1 country

Brahmi extractBacopaConditionally Safe

Shankhpushpi extractShankhpushpi—

Khurasani Ajwain powderHenbane—

Yashtimadhu powderLicorice —

ExcipientHeader—

ColourHeader—

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⛔ Contains an ingredient banned in ≥1 country

Ashwagandha 🇩🇰 🇧🇪 🇪🇺 — Banned April 2023 following DTU risk assessment. All products withdrawn.

3 Safety cross-reference

Selenium — Conditionally Safe

⚠ Selenosis >400 mcg

⚠ Diabetes risk at high doses

Ashwagandha — Banned in ≥1 country

⚠ Thyroid stimulation

⚠ HEPATOTOXICITY (rare but serious case reports)

Bacopa — Conditionally Safe

⚠ GI upset

⚠ May affect thyroid

4 Label claims

• All Other

5 Data source

DSLD ID203751

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2019-06-24

6 More from Herbal Hills

View Herbal Hills Safety Scorecard → 138 products

Alfalfa Alfalfa Alfalfa Green Food Supplement Alfalfa Green Food Supplement Alfalfa Powder Aloehills

7 Cite this page

Vancouver

Pkhakadze G. Migrahills — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Sep 01]. Available from: https://supplement.ge/products/migrahills-203751/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG